EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement

Irene Serrano-Gonzalo iD, Laura López de Frutos iD, Maria Sancho-Albero iD, Mercedes Roca-Espiau, Ralf Köhler iD, Pilar Giraldo iD

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Irene Serrano-Gonzalo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Española Para el Estudio y Tratamiento de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), Zaragoza, Spain. Hauptthemen laut MEDLINE: Exosomes, Gaucher Disease, MicroRNAs, Bone Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi, Fundación Española para el Estudio y Terapéutica de la Enfermedad de Gaucher y otras lisosomales (FEETEG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone manifestations are one of the most prevalent complications in patients with Gaucher disease (GD). Bone involvement is evaluated by using imaging methods, and there are different scores to assess its severity. However, there are no biomarkers that allow us to predict these manifestations. In recent years, several miRNAs have been associated with bone involvement and postulated as excellent bioavailable biomarkers. This study aims to identify a miRNA expression profile from plasma exosomes and to associate it with the severity of bone involvement in patients with GD. This study included 60 untreated patients with GD with bone involvement, who were classified according to the S‐MRI score into three groups: mild disease (MiBD; S‐MRI < 5), moderate disease (MoBD; S‐MRI: 5–11), or severe disease (SBD; S‐MRI > 11). Plasma exosomes were purified, and miRNAs were extracted and identified by next‐generation sequencing (NGS) technology. Differentially expressed miRNAs were validated by droplet digital PCR (ddPCR). In the patients' groups classified by S‐MRI, the median ages (Q1–Q3) were: MiBD 19.0 (4.00–40.00), MoBD 40.5 (28.25–56.00), and SBD 37.5 (31.25–47.00) years. When comparing groups, we found 12 differentially expressed exosomal miRNAs. After validation, four miRNAs were identified as differentially expressed: hsa‐miR‐127‐3p, hsa‐miR‐184, hsa‐miR‐197‐3p, and hsa‐miR‐660‐5p. Notably, hsa‐miR‐127‐3p, hsa‐miR‐660‐5p, and hsa‐miR‐184 were correlated with the presence of infarcts, necrosis, and the degree of infiltration into the spine, pelvis, and femur. These three miRNAs could serve as bioavailable biomarkers to assess bone disease in GD, and further revalidation with a higher number of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesGaucher DiseaseMicroRNAsBone DiseasesHumansMaleFemaleAdultBiomarkersYoung AdultAdolescentSeverity of Illness IndexMiddle AgedChildChild, PreschoolGene Expression ProfilingMagnetic Resonance Imaging

Stichwörter der Autor:innen

Gaucher diseasebiomarkersbone diseaseexosomesmiRNA

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Fundación Española Para el Estudio y Tratamiento de la Enfermedad de Gaucher y Otras Lisosomales (FEETEG), Zaragoza, Spain.
  • Department of Biochemistry and Molecular Biology, University of Zaragoza, Zaragoza, Spain.
  • Gaucher Disease Research Group (GIIS-012), Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain.
  • Grupo de Investigación Mecanismos de Enfermedad Crónica e Investigación Traslacional (MECIT), Zaragoza, Spain.
  • Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
  • Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, Spain.

ORCID-Profile: Irene Serrano-Gonzalo, Laura López de Frutos, Maria Sancho-Albero, Ralf Köhler, Pilar Giraldo

Förderung

  • Sanofi
  • Fundación Española para el Estudio y Terapéutica de la Enfermedad de Gaucher y otras lisosomales (FEETEG)

Zitieren

APA

Serrano-Gonzalo, I., López de Frutos, L., Sancho-Albero, M., Roca-Espiau, M., Köhler, R., & Giraldo, P. (2025). Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70061

Vancouver

Serrano-Gonzalo I, López de Frutos L, Sancho-Albero M, Roca-Espiau M, Köhler R, Giraldo P. Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70061

BibTeX
@article{SerranoGonzalo2025,
  author = {Serrano-Gonzalo, Irene and López de Frutos, Laura and Sancho-Albero, Maria and Roca-Espiau, Mercedes and Köhler, Ralf and Giraldo, Pilar},
  title = {Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70061}
}
Kostenlos starten →